A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
Príomhchruthaitheoir: | Shehab, Habibul Mohsin |
---|---|
Rannpháirtithe: | Yasmin, Hasina |
Formáid: | Tráchtas |
Teanga: | English |
Foilsithe / Cruthaithe: |
Brac University
2024
|
Ábhair: | |
Rochtain ar líne: | http://hdl.handle.net/10361/22683 |
Míreanna comhchosúla
-
Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
de réir: Tabassum, Nadira
Foilsithe / Cruthaithe: (2024) -
Signal detection of rhabdomyolysis and death for rivastigmine: a pharmacovigilance study
de réir: Mahee, Sadique Abdal
Foilsithe / Cruthaithe: (2024) -
Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
de réir: Alim, Abdul
Foilsithe / Cruthaithe: (2023) -
Signal detection of Rhabdomyolysis and death for galantamine: a pharmacovigilance study
de réir: Karmaker, Swastika
Foilsithe / Cruthaithe: (2024) -
A pharmacovigilance study on Donepezil: signal detection of rhabdomyolysis and death
de réir: Jahan, Nusrat
Foilsithe / Cruthaithe: (2023)